Carvolix Effectifs

Que fait Carvolix ? Carvolix, listed under the ticker CVX.PA with ISIN FR0013333077, is a health care company based in Aix-en-Provence, France. The company has 54 employees and completed its initial public offering (IPO) on June 14, 2021. Carvolix operates within the health care sector, focusing on medical technologies. Its website is https://www.affluentmedical.com/. The company develops minimally invasive prostheses designed to mimic human anatomy and restore native physiology for critical functions in cardiovascular and urological therapies. It provides transcatheter and flow control technologies, emphasizing minimally invasive implant procedures with optimized and biocompatible components. The company's product portfolio includes Kalios, Epygon, and Artus, which are used in treating conditions such as heart disease and urinary incontinence. Carvolix's approach centers on creating medical solutions that align with natural bodily functions, aiming to improve patient outcomes through innovative, less invasive procedures. The company's headquarters and operational base are located in Aix-en-Provence, a city in the Provence-Alpes-Côte d'Azur region of France. As a publicly traded entity since 2021, Carvolix continues to focus on advancing medical technologies within the health care industry. Carvolix est l'une des entreprises les plus populaires sur Eulerpool.